Literature DB >> 16128239

Current perspective on the pathogenesis of central diabetes insipidus.

Stefano Ghirardello1, Clara Malattia, Paola Scagnelli, Mohamad Maghnie.   

Abstract

Diabetes insipidus is a heterogeneous condition characterised by polyuria and polydipsia caused by a lack of secretion of vasopressin, its physiological suppression following excessive water intake, or kidney resistance to its action. The clinical and laboratory diagnosis is confirmed by standard tests, but recent advances in molecular biology and imaging techniques have shed new light on the pathophysiology of this disease. In many patients, central diabetes insipidus is caused by a germinoma or craniopharyngioma; Langerhans' cell histiocytosis and sarcoidosis of the central nervous system; local inflammatory, autoimmune or vascular diseases; trauma from surgery or accident; and, rarely, genetic defects in vasopressin biosynthesis inherited as autosomal dominant or X-linked recessive traits. Thirty to fifty percent of cases are considered idiopathic. Tumour-associated central diabetes insipidus is uncommon in children younger than 5 years old. Biopsy of enlarged pituitary stalk should be reserved for patients with hypothalamic-pituitary mass and progressive thickening of the pituitary stalk since spontaneous recovery may occur. Molecular biology in selected patients may identify those with apparently idiopathic diabetes insipidus carrying the vasopressin-neurophysin II gene mutation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16128239     DOI: 10.1515/jpem.2005.18.7.631

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  4 in total

1.  Causes and Follow-Up of Central Diabetes Insipidus in Children.

Authors:  Wendong Liu; Jing Hou; Xiuqin Liu; Limin Wang; Guimei Li
Journal:  Int J Endocrinol       Date:  2019-03-27       Impact factor: 3.257

2.  Permanent central diabetes insipidus with complete regression of pituitary stalk enlargement after 4 years of follow-up.

Authors:  Gönül Ocal; Zeynep Sıklar; Merih Berberoğlu; Pelin Bilir; Ozlem Engiz; Suat Fitoz; Serap Arıcı
Journal:  J Clin Res Pediatr Endocrinol       Date:  2008-08-06

3.  Management of diabetes insipidus in children.

Authors:  Garima Mishra; Sudha Rao Chandrashekhar
Journal:  Indian J Endocrinol Metab       Date:  2011-09

4.  Physiogenomics in Etiopathogenesis of Cholangiocarcinoma.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.